• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咽癌与自然杀伤细胞活性

Pharyngeal carcinoma and natural killer cell activity.

作者信息

Schantz S P, Campbell B H, Guillamondegui O M

出版信息

Am J Surg. 1986 Oct;152(4):467-74. doi: 10.1016/0002-9610(86)90326-0.

DOI:10.1016/0002-9610(86)90326-0
PMID:3766883
Abstract

An evaluation of natural killer cell activity was performed in 42 patients with pharyngeal carcinoma. Compared with age- and sex-matched control subjects, the cancer patients expressed significantly lower cytotoxicity against K562 target cells (68 +/- 8 lytic units versus 99 +/- 8 lytic units, p less than 0.01), with 52 percent of the patients expressing deficient activity (below 1 standard deviation of the mean activity of the control population). The probability of deficient activity was greater in these patients than observed in patients with cancer of other head and neck sites. Although natural killer cell activity was lower in patients who drank alcohol or had nodal metastases, no single clinical factor was predictive of deficient cytotoxic response. Prospective longitudinal evaluation (mean = 12 months) of these pharyngeal cancer patients demonstrated that deficient natural killer cell activity measured before treatment identified a population with a significantly increased risk for the development of distant metastases. Distant metastases developed in 7 of 18 patients (39 percent) with deficient natural killer cell activity. In contrast, none of the 16 patients with normal natural killer cell function had evidence of distant disease at last follow-up (p less than 0.01). Deficient natural killer cell activity exists in patients with pharyngeal cancer and is an independent marker for the subsequent development of distant metastases.

摘要

对42例咽癌患者进行了自然杀伤细胞活性评估。与年龄和性别匹配的对照受试者相比,癌症患者对K562靶细胞的细胞毒性显著降低(68±8个裂解单位对99±8个裂解单位,p<0.01),52%的患者表现出活性不足(低于对照人群平均活性的1个标准差)。这些患者活性不足的概率高于其他头颈部位癌症患者。虽然饮酒或有淋巴结转移的患者自然杀伤细胞活性较低,但没有单一临床因素可预测细胞毒性反应不足。对这些咽癌患者进行的前瞻性纵向评估(平均12个月)表明,治疗前测得的自然杀伤细胞活性不足可识别出远处转移发生风险显著增加的人群。18例自然杀伤细胞活性不足的患者中有7例(39%)发生了远处转移。相比之下,16例自然杀伤细胞功能正常的患者在最后一次随访时均无远处疾病证据(p<0.01)。咽癌患者存在自然杀伤细胞活性不足,且是远处转移后续发生的独立标志物。

相似文献

1
Pharyngeal carcinoma and natural killer cell activity.咽癌与自然杀伤细胞活性
Am J Surg. 1986 Oct;152(4):467-74. doi: 10.1016/0002-9610(86)90326-0.
2
Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
Laryngoscope. 1985 Nov;95(11):1391-400. doi: 10.1288/00005537-198511000-00020.
3
Natural killer cells and metastases from pharyngeal carcinoma.自然杀伤细胞与咽癌转移
Am J Surg. 1989 Oct;158(4):361-6. doi: 10.1016/0002-9610(89)90134-7.
4
Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.天然免疫在控制头颈癌转移扩散中作用的证据。
Cancer Immunol Immunother. 1987;25(2):141-8. doi: 10.1007/BF00199955.
5
Natural killer cell activity in laryngeal carcinoma.喉癌中的自然杀伤细胞活性
Arch Otolaryngol Head Neck Surg. 1993 Jan;119(1):69-72. doi: 10.1001/archotol.1993.01880130071010.
6
Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.鳞状细胞癌细胞上的人类白细胞抗原I类表达调节自然杀伤细胞活性。
Cancer Res. 1999 Nov 15;59(22):5793-9.
7
Prognostic significance of natural killer cell activity in patients with laryngeal carcinoma.
Arch Otolaryngol Head Neck Surg. 1998 Aug;124(8):852-6. doi: 10.1001/archotol.124.8.852.
8
[The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
Acta Otorhinolaryngol Ital. 1988 Mar-Apr;8(2):133-6.
9
Natural killer cell response to regional lymph node metastases.自然杀伤细胞对区域淋巴结转移的反应。
Arch Otolaryngol Head Neck Surg. 1986 May;112(5):545-51. doi: 10.1001/archotol.1986.03780050069012.
10
Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
Laryngoscope. 1978 Mar;88(3):470-83. doi: 10.1288/00005537-197803000-00011.

引用本文的文献

1
Analysis of Phenotypic and Molecular Variability of Memory-like NK Cells for Cancer Adoptive Cell Therapy Screening.用于癌症过继性细胞治疗筛选的记忆样自然杀伤细胞的表型和分子变异性分析。
Cancers (Basel). 2025 Jul 9;17(14):2288. doi: 10.3390/cancers17142288.
2
Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription.转录因子 E2F7 通过激活 RAD18 转录来阻碍 NK 细胞对结直肠癌细胞的杀伤作用。
J Microbiol Biotechnol. 2024 Apr 28;34(4):920-929. doi: 10.4014/jmb.2308.08026. Epub 2023 Nov 17.
3
Harnessing NK Cells to Control Metastasis.
利用自然杀伤细胞控制转移。
Vaccines (Basel). 2022 Nov 25;10(12):2018. doi: 10.3390/vaccines10122018.
4
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?先天免疫检查点抑制剂:肿瘤医学的下一个突破?
Mol Cancer Ther. 2021 Jun;20(6):961-974. doi: 10.1158/1535-7163.MCT-21-0041. Epub 2021 Apr 13.
5
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells.基于膜结合的 IL-21 的 NK 细胞饲养细胞可驱动 NK 细胞的强大扩增和代谢激活。
Sci Rep. 2019 Oct 17;9(1):14916. doi: 10.1038/s41598-019-51287-6.
6
Killers 2.0: NK cell therapies at the forefront of cancer control.杀手 2.0:NK 细胞疗法引领癌症控制新前沿。
J Clin Invest. 2019 Sep 3;129(9):3499-3510. doi: 10.1172/JCI129338.
7
NK Cell-Based Immunotherapy in Cancer Metastasis.基于自然杀伤细胞的癌症转移免疫疗法。
Cancers (Basel). 2018 Dec 28;11(1):29. doi: 10.3390/cancers11010029.
8
Natural killer cells and other innate lymphoid cells in cancer.自然杀伤细胞和癌症中的其他固有淋巴细胞。
Nat Rev Immunol. 2018 Nov;18(11):671-688. doi: 10.1038/s41577-018-0061-z.
9
Decreased NK cells in patients with head and neck cancer determined in archival DNA.存档 DNA 中检测到头颈部癌症患者 NK 细胞减少。
Clin Cancer Res. 2012 Nov 15;18(22):6147-54. doi: 10.1158/1078-0432.CCR-12-1008. Epub 2012 Sep 26.
10
CAM and NK Cells.细胞粘附分子与自然杀伤细胞
Evid Based Complement Alternat Med. 2004 Jun 1;1(1):17-27. doi: 10.1093/ecam/neh014.